TP-352

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameTP-352
Drug Alias Namemagnesium L-lysinate bis(docosahexaenoate)docosahexaenoic acid derivative (Thetis)TP-352DHA-FFA
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThetis Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesThetis Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A